Skip to main content

Sequence Biotech Announces Groundbreaking 96/384 Channel Benchtop Pipettor Compatible with LTS Tips

Amherst, NH - Sequence Biotech, a leading innovator in laboratory instruments and consumables, has unveiled its revolutionary benchtop pipettor, the first-ever 96/384 channel system compatible with the widely used LTS pipette tip format (trademarked by Mettler Toledo Rainin). This groundbreaking development offers significant advantages for researchers and laboratories worldwide.

“We are thrilled to introduce this innovative pipettor to the market,” said Daniel Seguin, founder and CEO of Sequence Biotech. “Our commitment to providing cutting-edge solutions for the scientific community led us to develop this unique system, offering unparalleled flexibility and compatibility.”

Sequence Biotech’s story began in 2009 with Seguin, a visionary design engineer with a passion for innovation. Leveraging his experience leading design initiatives at Thermo Fisher, Seguin established the company with the goal of creating groundbreaking solutions for the biotech industry.

The company’s journey is marked by the creation of its flagship product, the “Sorenson Benchtop Pipettor.” Developed in collaboration with Sorenson Biosciences® and subsequently manufactured by Sequence Biotech, this instrument established the company’s commitment to quality and precision.

In 2020, Sequence Biotech solidified its role as the sole provider of the “Sorenson Benchtop Pipettor,” assuming full manufacturing and service responsibilities. This transition not only streamlined operations but also allowed for continued exceptional service and support for customers. The instrument’s brand recognition further solidified Sequence Biotech’s reputation as a trusted partner within the scientific community.

The new 96/384 channel pipettor represents a significant leap forward, offering researchers the following advantages:

  • Unmatched Compatibility: The system seamlessly integrates with the widely adopted LTS pipette tip format, eliminating the need for researchers to switch tip types, streamlining workflows, and reducing costs.
  • Increased Efficiency: The 96/384 channel capability enables researchers to process samples in bulk, significantly increasing throughput and productivity.
  • Enhanced Precision: Sequence Biotech’s commitment to quality ensures accurate and reliable pipetting, a critical factor in successful research endeavors.


“Our new pipettor offers significant benefits for researchers worldwide,” said Seguin. “By combining innovative design with the industry-standard LTS tip format, we are empowering scientists to achieve more with greater efficiency and ease.”

Sequence Biotech remains dedicated to pushing the boundaries of innovation and providing researchers with the tools they need to advance scientific discovery. With a focus on delivering cutting-edge solutions, the company is poised to continue its growth trajectory, driven by the same passion and dedication that inspired its founder.

For more information please, visit their official website https://www.sequencebiotech.com/.

About Sequence Biotech

Sequence Biotech is a leading innovator in laboratory instruments and consumables. Founded in 2009 with a commitment to quality and efficiency, the company has established itself as a trusted partner for researchers and laboratories worldwide. Their dedication to cutting-edge solutions empowers scientists to achieve groundbreaking results.

Media Contact
Company Name: Sequence Biotech
Contact Person: Daniel Seguin (business owner)
Email: Send Email
Country: United States
Website: https://www.sequencebiotech.com/


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.